Display options
Share it on

BMC Res Notes. 2011 Oct 21;4:433. doi: 10.1186/1756-0500-4-433.

Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TX.

BMC research notes

Rohina Rubicz, Charles T Leach, Ellen Kraig, Nikhil V Dhurandhar, Barry Grubbs, John Blangero, Robert Yolken, Harald Hh Göring

Affiliations

  1. Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX 78245-0549, USA. [email protected].

PMID: 22018212 PMCID: PMC3214184 DOI: 10.1186/1756-0500-4-433

Abstract

BACKGROUND: Infection risks vary among individuals and between populations. Here we present information on the seroprevalence of 13 common infectious agents in a San Antonio-based sample of Mexican Americans. Mexican Americans represent the largest and most rapidly growing minority population in the U.S., and they are also considered a health disparities population.

METHODS: We analyzed 1227 individuals for antibody titer to Chlamydophila pneumoniae, Helicobacter pylori, Toxoplasma gondii, cytomegalovirus, Epstein-Barr virus, herpes simplex virus-1, herpes simplex virus-2 (HSV-2), human herpesvirus-6 (HHV-6), varicella zoster virus (VZV), adenovirus-36, hepatitis A virus, and influenza A and B. Seroprevalence was examined as a function of sex, age, household income, and education.

RESULTS: Seroprevalence estimates ranged from 9% for T. gondii to 92% for VZV, and were similar in both sexes except for HSV-2, which was more prevalent in women. Many pathogens exhibited a significant seroprevalence change over the examined age range (15-94 years), with 7 pathogens increasing and HHV-6 decreasing with age. Socioeconomic status significantly correlated with serostatus for some pathogens.

CONCLUSIONS: Our findings demonstrate substantial seroprevalence rates of these common infections in this sample of Mexican Americans from San Antonio, Texas that suffers from high rates of chronic diseases including obesity and type-2 diabetes.

References

  1. J Infect. 1995 Mar;30(2):121-8 - PubMed
  2. MMWR Morb Mortal Wkly Rep. 2007 Jul 13;56(27):678-81 - PubMed
  3. Am J Hum Genet. 1998 May;62(5):1198-211 - PubMed
  4. J Med Virol. 2003;70 Suppl 1:S111-8 - PubMed
  5. Am J Epidemiol. 2001 May 1;153(9):912-20 - PubMed
  6. Am J Hum Genet. 1999 Apr;64(4):1127-40 - PubMed
  7. Clin Infect Dis. 2010 Jun 1;50(11):1439-47 - PubMed
  8. Stroke. 2003 Mar;34(3):610-5 - PubMed
  9. Int J Obes Relat Metab Disord. 2000 Aug;24(8):989-96 - PubMed
  10. J Biochem Biophys Methods. 1986 Aug;13(1):47-51 - PubMed
  11. Ann Hum Genet. 1976 May;39(4):485-91 - PubMed
  12. Pathol Int. 2002 Jan;52(1):31-9 - PubMed
  13. Am J Hum Genet. 2006 Mar;78(3):377-92 - PubMed
  14. Am J Cardiol. 2003 Sep 1;92(5):515-21 - PubMed
  15. Viral Immunol. 2004;17(2):308-14 - PubMed
  16. JAMA. 1969 Jun 2;208(9):1675-9 - PubMed
  17. Clin Microbiol Infect. 2006 Feb;12(2):118-22 - PubMed
  18. Arch Intern Med. 2000 Jul 10;160(13):2027-32 - PubMed
  19. Intern Med J. 2003 Jul;33(7):267-72 - PubMed
  20. Microbes Infect. 2003 Jul;5(8):705-13 - PubMed
  21. Int J Obes (Lond). 2005 Mar;29(3):281-6 - PubMed
  22. Clin Infect Dis. 2001 May 15;32(10):1387-92 - PubMed
  23. Clin Rev Allergy Immunol. 2012 Apr;42(2):154-63 - PubMed
  24. J Infect Dis. 1990 Jan;161(1):153-4 - PubMed
  25. Lancet. 1988 Oct 29;2(8618):983-6 - PubMed
  26. Lancet. 1988 Aug 13;2(8607):396 - PubMed
  27. Am J Cardiol. 2000 Jan 15;85(2):140-6 - PubMed
  28. Circulation. 2002 Jan 1;105(1):15-21 - PubMed
  29. Int J Obes (Lond). 2009 Dec;33(12):1402-9 - PubMed
  30. Am J Trop Med Hyg. 2007 Sep;77(3):405-10 - PubMed
  31. Am J Epidemiol. 1984 Dec;120(6):834-51 - PubMed
  32. Stroke. 2002 Nov;33(11):2581-6 - PubMed
  33. J Infect Dis. 1999 Aug;180(2):509-13 - PubMed
  34. J Infect Dis. 2002 Oct 15;186 Suppl 1:S3-28 - PubMed
  35. JAMA. 2006 Aug 23;296(8):964-73 - PubMed
  36. Int J Obes (Lond). 2010 Jan;34(1):89-93 - PubMed
  37. Clin Infect Dis. 1995 May;20(5):1174-8 - PubMed
  38. Genet Epidemiol. 1997;14(6):987-92 - PubMed
  39. Circulation. 2001 Jul 3;104(1):25-31 - PubMed
  40. Vaccine. 2005 Dec 30;23(50):5798-806 - PubMed
  41. Circulation. 2001 Jan 2;103(1):45-51 - PubMed
  42. J Gerontol A Biol Sci Med Sci. 2009 Feb;64(2):272-9 - PubMed
  43. Lupus. 2009 Nov;18(13):1154-68 - PubMed
  44. J Med Virol. 2009 Feb;81(2):325-31 - PubMed
  45. J Clin Immunol. 2009 Nov;29(6):714-21 - PubMed
  46. Epidemiology. 2009 Nov;20(6):902-8 - PubMed
  47. Am J Public Health. 2004 Nov;94(11):1952-8 - PubMed
  48. Ethn Dis. 2006 Spring;16(2):534-41 - PubMed
  49. Circulation. 2003 Jan 21;107(2):220-2 - PubMed
  50. Int J Obes (Lond). 2010 Feb;34(2):302-8 - PubMed
  51. J Infect Dis. 2000 Apr;181(4):1359-63 - PubMed
  52. J Pediatr. 1992 Aug;121(2):173-81 - PubMed
  53. Circulation. 2003 May 27;107(20):2566-70 - PubMed
  54. J Infect Dis. 2001 Aug 1;184(3):390-1 - PubMed
  55. J Infect Dis. 2000 Dec;182(6):1583-7 - PubMed
  56. Circulation. 1996 Nov 1;94(9):2159-70 - PubMed
  57. Curr Top Microbiol Immunol. 2008;325:397-415 - PubMed
  58. Diabetes. 2005 Sep;54(9):2655-62 - PubMed
  59. Emerg Infect Dis. 2003 Nov;9(11):1371-4 - PubMed
  60. Clin Infect Dis. 1992 Mar;14(3):741-6 - PubMed

Publication Types

Grant support